Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Illinois · 104th Regular Session · Bill

HB 5255: MEDICAID-SICKLE CELL DISEASE

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

HB 5255 is a bill introduced in the Illinois House on February 5, 2026. According to its official title, it concerns: MEDICAID-SICKLE CELL DISEASE. Primary sponsor: Camille Lilly (Democratic). It lists 1 additional sponsor. Most recent recorded action (March 27, 2026): Rule 19(a) / Re-referred to Rules Committee.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Sponsors

Sponsors by party (alphabetical): Democratic 2

NameRolePartyChamberDistrict
Camille LillyPrimary sponsorDemocraticHouse78
Laura Faver DiasCo-sponsorDemocraticHouse62

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. Rule 19(a) / Re-referred to Rules Committee
  2. Assigned to Human Services Committee
  3. Added Co-Sponsor Rep. Laura Faver Dias
  4. Referred to Rules Committee
  5. First Reading
  6. Filed with the Clerk by Rep. Camille Y. Lilly

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source